0001213900-20-014434.txt : 20200608 0001213900-20-014434.hdr.sgml : 20200608 20200608175915 ACCESSION NUMBER: 0001213900-20-014434 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200525 FILED AS OF DATE: 20200608 DATE AS OF CHANGE: 20200608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Luzon Ronen CENTRAL INDEX KEY: 0001686315 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37370 FILM NUMBER: 20950290 MAIL ADDRESS: STREET 1: 3 ARAVA ST. P.O.B 1026 CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: My Size, Inc. CENTRAL INDEX KEY: 0001211805 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: HAYARDEN 4 CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 BUSINESS PHONE: 972-36009030 MAIL ADDRESS: STREET 1: HAYARDEN 4 CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 FORMER COMPANY: FORMER CONFORMED NAME: Mysize Inc. DATE OF NAME CHANGE: 20150317 FORMER COMPANY: FORMER CONFORMED NAME: TOPSPIN MEDICAL INC DATE OF NAME CHANGE: 20021226 4 1 ownership.xml X0306 4 2020-05-25 0 0001211805 My Size, Inc. MYSZ 0001686315 Luzon Ronen HAYARDEN 4 AIRPORT CITY L3 7010000 ISRAEL 1 1 0 0 Chief Executive Officer Option to purchase Common Stock (right to buy) 18.15 2020-05-25 4 D 0 10000 D 2022-07-24 Common Stock, $.001 par value per share 10000 0 D Option to purchase Common Stock (right to buy) 1.04 2020-05-25 4 A 0 10000 A 2023-07-24 Common Stock, $.001 par value per share 10000 10000 D Option to purchase Common Stock (right to buy) 11.4 2020-05-25 4 D 0 6667 D 2024-05-29 Common Stock, $.001 par value per share 6667 0 D Option to purchase Common Stock (right to buy) 1.04 2020-05-25 4 A 0 6667 A 2025-05-29 Common Stock, $.001 par value per share 6667 6667 D Option to purchase Common Stock (right to buy) 11.4 2020-05-25 4 D 0 33334 D 2024-05-29 Common Stock, $.001 par value per share 33334 0 D Option to purchase Common Stock (right to buy) 1.04 2020-05-25 4 A 0 33334 A 2025-05-29 Common Stock, $.001 par value per share 33334 33334 D Option to purchase Common Stock (right to buy) 18.15 2020-05-25 4 D 0 10000 D 2022-07-24 Common Stock, $.001 par value per share 10000 0 I See Footnote Option to purchase Common Stock (right to buy) 1.04 2020-05-25 4 A 0 10000 A 2023-07-24 Common Stock, $.001 par value per share 10000 10000 I See Footnote Option to purchase Common Stock (right to buy) 11.4 2020-05-25 4 D 0 5334 D 2024-05-29 Common Stock, $.001 par value per share 5334 0 I See Footnote Option to purchase Common Stock (right to buy) 1.04 2020-05-25 4 A 0 5334 A 2025-05-29 Common Stock, $.001 par value per share 5334 5334 I See Footnote Option to purchase Common Stock (right to buy) 11.4 2020-05-25 4 D 0 17000 D 2024-05-29 Common Stock, $.001 par value per share 17000 0 I See Footnote Option to purchase Common Stock (right to buy) 1.04 2020-05-25 4 A 0 17000 A 2025-05-29 Common Stock, $.001 par value per share 17000 17000 I See Footnote Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on January 24, 2019, one third of the total shares vested on January 24, 2020 and the remaining one third of the total shares vests on January 24, 2021. Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). On November 15, 2019, the Company implemented a 1-for-15 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split. /s/ Ronen Luzon 2020-06-08